Astec Lifesciences was locked at 20% upper circuit at Rs 165.60 at 14:19 IST on BSE after consolidated net profit rose 101.9% to Rs 3.25 crore on 97% growth in net sales to Rs 91.98 crore in Q4 March 2015 over Q4 March 2014.
The Q4 result was announced before market hours today, 18 May 2015.
Meanwhile, the S&P BSE Sensex was up 209.85 points or 0.77% at 27,533.85.
On BSE, so far 4.19 lakh shares were traded in the counter as against average daily volume of 1.34 lakh in past one quarter.
The stock hit a low of Rs 146 so far during the day. The stock had hit a record high of Rs 172.70 on 15 April 2015. The stock had hit a 52-week low of Rs 37.65 on 19 May 2014.
The stock had underperformed the market over the past one month till 15 May 2015, sliding 17.22% compared with Sensex's 5.12% fall. The scrip had, however, outperformed the market in past one quarter, jumping 14.19% as against Sensex's 6.09% fall.
The small-cap company has equity capital of Rs 18.53 crore. Face value per share is Rs 10.
Astec Lifesciences makes a wide range of agrochemical active ingredients and pharmaceutical intermediates.
Powered by Capital Market - Live News
